PACIRA BIOSCIENCES INC (PCRX)
US6951271005 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to PCRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 46.24. This target is 75.62% above the current price.
PCRX was analyzed by 16 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about PCRX.
In the previous month the buy percentage consensus was at a similar level.
PCRX was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-09 | Needham | Reiterate | Buy -> Buy |
| 2024-03-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-01 | Needham | Reiterate | Buy -> Buy |
| 2024-03-01 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-08 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-12-20 | Raymond James | Initiate | Outperform |
| 2023-11-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-03 | Needham | Maintains | Buy -> Buy |
| 2023-11-03 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-11-03 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-10-23 | Barclays | Maintains | Overweight -> Overweight |
| 2023-10-03 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-08-03 | TD Cowen | Upgrade | Market Perform -> Outperform |
| 2023-08-03 | Needham | Maintains | Buy -> Buy |
| 2023-08-03 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-08-03 | Truist Securities | Maintains | Buy -> Buy |
| 2023-08-03 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-08-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-04 | RBC Capital | Maintains | Outperform |
| 2023-05-04 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-20 | Needham | Reiterate | Buy |
| 2023-03-01 | RBC Capital | Maintains | Outperform |
| 2023-03-01 | HC Wainwright & Co. | Maintains | Buy |
| 2023-02-28 | Needham | Maintains | Buy |
| 2023-02-10 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-06 | BMO Capital | Maintains | Market Perform |
| 2023-01-06 | Needham | Maintains | Buy |
| 2022-11-07 | BMO Capital | Maintains | Market Perform |
| 2022-11-04 | HC Wainwright & Co. | Maintains | Buy |